Table 1.
High throughput DNA methylome profiling in inflammatory bowel disease
Ref. | Disease | Tissue/cell | Array platform | Significant differential methylation | GWAS overlap |
Human patients | |||||
Lin et al[73] | UC and CD | Intestinal | Illumina goldengate | 7 CpG sites | Not reported |
Cooke et al[66] | UC and CD | Rectal | Illumina infinium human methylation 27 | 3604 (UC) and 472 (CD) loci | Yes |
Lin et al[72] | UC and CD | B cell | Illumina goldengate | 24 (UC) and 14 (CD) CpG sites | Not reported |
Häsler et al[69] | UC | Intestinal | Illumina human methylation 27 and nimblegen custom 385K | 61 loci | No |
Nimmo et al[67] | CD | Whole blood | Illumina human methylation 27 | 1117 CpG sites | Yes |
Mouse | |||||
Kellermayer et al[59] | DSS colitis (postnatal day 30 vs day 90) | Colon | Custom array (Agilent) | 271 intervals | Not reported |
Kellermayer et al[58] | Tlr2-/- | Colon | Custom array (Agilent) | 387 intervals | Not reported |
UC: Ulcerative colitis; CD: Crohn’s disease; GWAS: Genome-wide association studies; DSS: Dextran sulfate sodium.